Pages that link to "Q43986093"

The following pages link to Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels (Q43986093):

Displaying 21 items.

• Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring (Q27027293) (← links)
• Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response (Q28390146) (← links)
• Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. (Q30372214) (← links)
• Sertraline Induces Toxicity and Behavioral Alterations in Planarians (Q30855118) (← links)
• Serum BDNF levels before treatment predict SSRI response in depression (Q35173385) (← links)
• A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder (Q35737882) (← links)
• Therapeutic drug monitoring of non-tricyclic antidepressant drugs (Q35970340) (← links)
• Blockade of Kv1.5 channels by the antidepressant drug sertraline (Q36627616) (← links)
• Dysregulated relationship of inflammation and oxidative stress in major depression. (Q36892222) (← links)
• Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety. (Q38120061) (← links)
• Pharmacokinetics of antidepressants in patients with hepatic impairment (Q38253564) (← links)
• Effect of sertraline on [Ca2 ](i) and viability of human MG63 osteosarcoma cells (Q39289001) (← links)
• The mechanism of sertraline-induced [Ca(2 ) ](i) rise in human PC3 prostate cancer cells. (Q39582267) (← links)
• The mechanism of sertraline-induced [Ca2 ]i rise in human OC2 oral cancer cells. (Q39605710) (← links)
• Effect of the antidepressant sertraline on Ca2 fluxes in Madin-Darby canine renal tubular cells (Q39780366) (← links)
• Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels. (Q42619331) (← links)
• Long-term efficacy and therapeutic drug monitoring of sertraline in major depression (Q44511466) (← links)
• Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients (Q46447657) (← links)
• Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice (Q46800432) (← links)
• Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation (Q47984936) (← links)
• Evidence for cardiotoxicity associated with sertraline in rats (Q57497842) (← links)